Korea

Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology

SEONGNAM, South Korea and AURORA, Colo., March 26, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330) , a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr.Raul...

2024-03-27 06:00 711

EIPGRID Acquires FE and Ventures into 'VPP+EaaS' Business

* EIPGRID, a renowned global provider of community energy solutions, embarks on a groundbreaking initiative by launching its own community energy service in Jeju Island, Korea. * This marks the first step and a significant leap towards establishing the innovative 'VPP+EaaS' business ecosystem...

2024-03-27 00:00 594

Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients

- New research published in Clinical Cancer Research shows significant improvement in distant recurrence-free survival with combined durvalumab and tremelimumab treatment, supported by Lunit SCOPE IO's analysis of tumor microenvironment SEOUL, South Korea, March 26, 2024 /PRNewswire/ -- Lunit (K...

2024-03-26 21:00 1228

TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B Patients

* TU7710 has the potential to be a highly effective and long-acting treatment for bleeding episodes as well as for preventing bleeding during surgery or invasive procedures in hemophilia patients with inhibitors * Interim results from an ongoing Phase 1a study in healthy male volunteers will ...

2024-03-26 20:00 1058

GC Genome to Present New Data at AACR 2024

Offering Hope for Enhanced Early Detection and Patient Care in the Battle Against Cancer YONGIN, South Korea, March 25, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that the company will present two poster presentations at the American Association fo...

2024-03-25 21:00 1499

Squirrel Ai showcases L5-level Large Adaptive Model at AI Summit Seoul

The AI adaptive education Unicorn company engages in forward-looking discussions on AI's future with industry giants SEOUL, South Korea, March 25, 2024 /PRNewswire/ -- Dr. Joleen Liang, the co-founder of Squirrel Ai Learning, took the stage as a keynote speaker at the 6th AI Summit Seoul, a pres...

2024-03-25 19:06 1815

Tripbtoz Unveils Revolutionary Travel-to-Earn Service at SXSW 2024

- Blending virtual and real travel into a unified experience - " In tune with K-culture's popularity, we aim to unite diverse cultures and people " SEOUL, South Korea, March 22, 2024 /PRNewswire/ -- Tripbtoz (CEO Jiha Jung) announced that it participated in South by Southwest 2024 (SXSW 2024) inA...

2024-03-22 13:23 1700

BANF Smart Tire collaborates with CampX by Volvo Group

Collaboration Redefining Intelligent Tire Technology Efficacy. SEOUL, South Korea, March 21, 2024 /PRNewswire/ -- BANF, a leader in smart tire technology, collaborates with CampX by Volvo Group in a Proof of Value (PoV) project, co-creating on intelligent tire safety and fuel efficiency optimiza...

2024-03-22 08:01 1628

FDA Grants Orphan Drug Designation to Cevidoplenib for ITP

PANGYO, South Korea, March 21, 2024 /PRNewswire/ -- Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for its SYK inhibitor, Cevidoplenib, to treat immune thrombocytopenia (ITP). Oscotec has successfully completed phase 2 study in patients wit...

2024-03-21 20:00 1600

HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update

* Full-year 2023 net revenue reaches 135 billion KRW, driven by strong sales growth. * R&D momentum persisted with promising developments in anti-FcRn antibodies HL161ANS and batoclimab, positioning them as potentially best-in-class treatments for lgG-mediated autoimmune diseases. * Anticip...

2024-03-21 19:00 1697

Widely Popular 'Honey Oranda Snack Bar' from YoungManDduk makes its US debut at Costco

SEOUL, South Korea, March 20, 2024 /PRNewswire/ -- Popular Korean Food brand, 'YoungManDduk', will be making its US debut with their beloved Honey Oranda Snack Bars through Costco. The snack combines both Korea's authentic flavors and modern cuisine, creating a brand-new culinary innovation.

2024-03-21 08:34 1523

#PatThePeptide TikTok Challenge Sparks Surge in Demand: COSRX's The 6 Peptide Skin Booster Serum Sells Out Across Platforms within One Week

LOS ANGELES, March 19, 2024 /PRNewswire/ -- Within just one week of its launch onMarch 7th, the #PatThePeptide TikTok Challenge has ignited a phenomenal response, resulting in the rapid depletion of COSRX'sThe 6 Peptide Skin Booster Serum

2024-03-20 09:12 1535

NETMARBLE OPENS GLOBAL PRE-REGISTRATION FOR UPCOMING ACTION RPG SOLO LEVELING:ARISE

Early Access Available for Canadian Players Starting March 21 LOS ANGELES, March 19, 2024 /PRNewswire/ -- Netmarble, a leading developer and publisher of high-quality mobile games, opened pre-registration globally for its upcoming mobile and PC gameSolo Leveling:ARISE, and beginning March 21, Ea...

2024-03-20 01:00 1722

SK hynix Begins Volume Production of Industry's First HBM3E

* SK hynix extends success of HBM3, marking first case in industry to mass produce HBM3E * Supply to a customer comes in 7 months after development announced; best-in-class performance to lead level of AI capabilities to world's best * SK hynix to cement position as global top provider of AI...

2024-03-19 10:21 1243

Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

* New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to the Central region branch of the Portuguese League Against Cancer SEOUL, South Korea, March 18, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diag...

2024-03-18 21:00 1839

/DISREGARD RELEASE: AIMMO Inc/

We are advised by AIMMO Inc that journalists and other readers should disregard the news release, AIMMO Enters Partnership with Mitsubishi Electric for Data Supply, issued13-Mar-2024 over PR Newswire, as the release contained erroneous information. ...

2024-03-15 14:05 2622

Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research

- Lunit SCOPE HER2 and Lunit SCOPE ER/PR significantly improve pathologist concordance and accuracy, paving the way for improved breast cancer molecular subtype analysis for informed decision-making and precision patient care SEOUL, South Korea, March 14, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ...

2024-03-14 21:00 1894

SurplusGLOBAL Leads with Sustainable Value Creation Based on Legacy Semiconductor Equipment at SEMICON China 2024

SEOUL, South Korea, March 13, 2024 /PRNewswire/ -- SurplusGLOBAL (Booth No. N2351), a leader in the legacy semiconductor equipment sector, is set to make a significant impact at SEMICONCHINA 2024. The company, specializing in legacy semiconductor equipment and parts, plans to showcase customized ...

2024-03-13 22:00 1939

Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured

- Volpara shareholder meeting to be held on April 12, 2024: Culminating the acquisition journey for Lunit, finalization set for May SEOUL, South Korea, March 13, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

2024-03-13 21:00 1767

AITRICS to Participate in HIMSS USA 2024

- Three consecutive years of participation in HIMSS USA - Showcasing 'VitalCare' which is an AI Solution for Predicting Patient Deterioration. SEOUL, South Korea, March 12, 2024 /PRNewswire/ -- AITRICS (CEO Kwang joon Kim), a company specializing in medical artificial intelligence (AI) technology...

2024-03-12 22:50 1727
1 ... 17181920212223 ... 110